2 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 3 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 1, Not yet recruiting 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow Neurasthenia: new trials by email Literature Review of Neurasthenia trials Research Report on Neurasthenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exposure Therapy for Reactivity to Symptoms Planned, systematic, exposure exercises, Response prevention - Psychological Factors Affecting Other Medical Conditions, Somatic Symptom and Related Disorders | Not applicable | Not yet recruiting | Region Stockholm | 360 | 2026-09-01 | 2026-08-11 |
| Efficacy and Safety of Ranquilon in Patients With Anxiety Disorders Due to Neurasthenia and Adjustment Disorders Ranquilon, Afobazole - Anxiety, Neurasthenia | Phase 4 | Recruiting | Valenta Pharm JSC | 250 | 2025-01-13 | 2025-07-08 |
| A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders Ranquilon, Placebo - Anxiety, Neurasthenia | Phase 3 | Completed | Valenta Pharm JSC | 220 | 2022-10-12 | 2023-07-27 |
| Effectiveness of Mind-Body Interventions for Frequent Attendees Suffering From Medically Unexplained Symptoms (MUS) Medical and Psychological treatment - Neurasthenia, Chronic Pain | Not applicable | Terminated | Soroka University Medical Center | 15 | 2016-01-01 | 2019-04-05 |
| Mindfulness-based Cognitive Therapy for Patients With Functional Disorders Mindfulness-Based Cognitive Therapy for Functional Disorders - Somatization Disorder, Functional Disorders | Not applicable | Completed | University of Aarhus | 150 | 2007-06-01 | 2011-11-16 |
Adjustment Disorders (2) · Anxiety Disorders (2) · Medically Unexplained Symptoms (2) · Chronic Pain (1) · Headache Disorders (1) · Somatoform Disorders (1)
Mental Disorders (5) · Somatoform Disorders (4) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Trauma and Stressor Related Disorders (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Pain (1)
GB-115 (2) · 2-((2-morpholino)ethylthio)-5-ethoxybenzimidazole (1) · Mindfulness-Based Cognitive Therapy (1)
Valenta Pharm JSC (2) · Region Stockholm (1) · Soroka University Medical Center (1) · University of Aarhus (1)
Russia (2) · Denmark (1) · Israel (1) · Sweden (1)
Erland Axelsson, PhD (1) · Per Fink, DMSc (1) · Yacov Ezra, MD (1)